Medicale Corp. Confirms Going Concern, Zero Cash, and Ineffective Controls in Latest 10-Q

summarizeSummary

Medicale Corp.'s 10-Q reiterates severe financial distress with a going concern warning and zero cash, despite a reduced quarterly loss and new, small convertible note financing, while also disclosing ineffective internal controls.

check_boxKey Events

• Continued Going Concern Warning

  The company reiterates substantial doubt about its ability to continue as a going concern, with an accumulated deficit of $222,288 and a working capital deficit of $32,202 as of December 31, 2025.

• Zero Cash Position

  Medicale Corp. reported zero cash and cash equivalents as of December 31, 2025, highlighting severe liquidity challenges.

• New Convertible Note Financing

  The company secured a new convertible note for $6,740 on December 31, 2025, with a conversion price of $0.15 per share, significantly above the current stock price.

• Reduced Quarterly Net Loss

  Net loss for the three months ended December 31, 2025, decreased to $5,290 from $16,680 in the prior year's comparable period.

auto_awesomeAnalysis

This 10-Q filing confirms Medicale Corp.'s ongoing severe financial distress, reiterating a going concern warning and zero cash position. While the company reported a reduced net loss for the quarter and secured a small convertible note, the overall financial health remains critical. The disclosure of ineffective internal controls over financial reporting adds a significant governance concern, indicating a lack of segregation of duties in financial processes.